Arzneimittel-Forschung 1997-06-01

[Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation].

J E Metzner, D Buchberger, N Häring, J Läuter

文献索引：Arzneimittelforschung 47(6) , 719-26, (1997)

全文：HTML全文

摘要

An investigation in the bioequivalence of a new tablet formulation with 5 mg isosorbide dinitrate (CAS 87-33-2, ISDN 5 von ct) was performed in a two-way cross-over study with 18 subjects. The relative bioavailability with respect to a reference preparation for AUC related to isosorbide dinitrate was 107.5% and for Cmax 112.5%. A positive decision for bioequivalence derived from the usual confidence intervals for both parameters related to isosorbide dinitrate and the metabolites isosorbide-2-nitrate and isosorbide-5-nitrate, respectively. The difference in tmax showed no clinical relevance. The new formulation was bioequivalent to the reference.

相关化合物

  • 2-硝酸异山梨酯

相关文献：

Effects of isosorbide-5-mononitrate and isosorbide-2-mononitrate on isolated dog aorta: vascular relaxation and increase in cyclic GMP.

1991-01-01

[Arch. Int. Pharmacodyn. Ther. 312 , 104-9, (1991)]

Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats.

1992-05-01

[J. Pharmacol. Exp. Ther. 261(2) , 692-700, (1992)]

Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.

1990-01-01

[Eur. J. Clin. Pharmacol. 38(2) , 145-7, (1990)]

A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.

1990-01-01

[Drug Metab. Dispos. 18(4) , 429-34, (1990)]

Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.

1993-01-01

[Pharm. Res. 10(1) , 22-7, (1993)]

更多文献...